Humacyte (HUMA) Other Working Capital Changes (2021 - 2025)
Humacyte (HUMA) posted quarterly Other Working Capital Changes of -$15000.0 for Q3 2025, down 15.38% year-over-year from -$17727.3 in Q3 2024, and little changed quarter-over-quarter from -$15000.0 in Q2 2025.
Humacyte (HUMA) Other Working Capital Changes (2021 - 2025) Analysis & Trends
Humacyte (HUMA) has reported Other Working Capital Changes for 5 consecutive years, with -$15000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Other Working Capital Changes fell 15.38% year-over-year to -$15000.0; the TTM figure through Mar 2026 stood at -$30000.0 (up 44.44% YoY), while the FY2025 annual figure was -$44000.0, up 16.98% from the prior year.
- Other Working Capital Changes was little changed at -$15000.0 in Q3 2025 per HUMA's latest filing, from -$15000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at -$10000.0 in Q2 2021 and bottomed at -$15000.0 in Q2 2025.
- Historically, Other Working Capital Changes has averaged -$12315.8 across 5 years, with a median of -$12000.0 in 2022.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes changed 0.0% — and 2023, when it declined 18.18%.
- Humacyte's Other Working Capital Changes stood at -$10000.0 in 2021, then declined by 10.0% to -$11000.0 in 2022, then dropped by 18.18% to -$13000.0 in 2023, then slipped by 7.69% to -$14000.0 in 2024, then retreated by 7.14% to -$15000.0 in 2025.
- Business Quant data shows HUMA's Other Working Capital Changes at -$15000.0 in Q3 2025, -$15000.0 in Q2 2025, and -$14000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Humacyte | 158.12 Mn | 158.12 Mn | -825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -15,000.00 |
| Sep 30, 2025 | -15,000.00 |
| Sep 30, 2025 | -15,000.00 |
| Jun 30, 2025 | -15,000.00 |
| Jun 30, 2025 | -15,000.00 |
| Jun 30, 2025 | -15,000.00 |
| Mar 31, 2025 | -14,000.00 |
| Mar 31, 2025 | -14,000.00 |
| Mar 31, 2025 | -14,000.00 |
| Dec 31, 2024 | -14,000.00 |
| Dec 31, 2024 | -14,000.00 |
| Dec 31, 2024 | -14,000.00 |
| Sep 30, 2024 | -13,000.00 |
| Sep 30, 2024 | -13,000.00 |
| Sep 30, 2024 | -13,000.00 |
| Jun 30, 2024 | -13,000.00 |
| Jun 30, 2024 | -13,000.00 |
| Jun 30, 2024 | -13,000.00 |
| Mar 31, 2024 | -13,000.00 |
| Mar 31, 2024 | -13,000.00 |